A Simon Harvey1, Simone A Mandelstam2, Wirginia J Maixner2, Richard J Leventer2, Mira Semmelroch2, Duncan MacGregor2, Renate M Kalnins2, Yuliya Perchyonok2, Gregory J Fitt2, Sarah Barton2, Michael J Kean2, Gavin C A Fabinyi2, Graeme D Jackson2. 1. From the Departments of Neurology (A.S.H., R.J.L., G.D.J.), Medical Imaging (S.A.M., M.J.K.), Neurosurgery (W.J.M.), and Anatomical Pathology (D.M.), The Royal Children's Hospital, Parkville; Departments of Neurology (G.D.J.), Radiology (Y.P., G.J.F.), Neurosurgery (G.C.A.F.), and Anatomical Pathology (R.M.K.), Austin Health, Heidelberg; Departments of Paediatrics (A.S.H., S.A.M., R.J.L.), Medicine (G.D.J.), Surgery (G.C.A.F.), Pathology (D.M., R.M.K.), and Radiology (S.A.M., Y.P., G.J.F.), The University of Melbourne; Florey Institute of Neuroscience and Mental Health (A.S.H., S.A.M., M.S., G.D.J.), Heidelberg; Neurosciences (A.S.H., W.J.M., R.J.L.) and Developmental Imaging (S.B., M.J.K.) Groups, Murdoch Children's Research Institute, Parkville, Australia. simon.harvey@rch.org.au. 2. From the Departments of Neurology (A.S.H., R.J.L., G.D.J.), Medical Imaging (S.A.M., M.J.K.), Neurosurgery (W.J.M.), and Anatomical Pathology (D.M.), The Royal Children's Hospital, Parkville; Departments of Neurology (G.D.J.), Radiology (Y.P., G.J.F.), Neurosurgery (G.C.A.F.), and Anatomical Pathology (R.M.K.), Austin Health, Heidelberg; Departments of Paediatrics (A.S.H., S.A.M., R.J.L.), Medicine (G.D.J.), Surgery (G.C.A.F.), Pathology (D.M., R.M.K.), and Radiology (S.A.M., Y.P., G.J.F.), The University of Melbourne; Florey Institute of Neuroscience and Mental Health (A.S.H., S.A.M., M.S., G.D.J.), Heidelberg; Neurosciences (A.S.H., W.J.M., R.J.L.) and Developmental Imaging (S.B., M.J.K.) Groups, Murdoch Children's Research Institute, Parkville, Australia.
Abstract
OBJECTIVE: To determine clinical and EEG features that might help identify patients with epilepsy harboring small, intrinsically epileptogenic, surgically treatable, bottom-of-sulcus dysplasias (BOSDs). METHODS: Retrospective review of clinical records, EEG, MRI, and histopathology in 32 patients with drug-resistant epilepsy and MRI-positive (72% 3.0 tesla), pathologically proven (type 2B cortical dysplasia) BOSDs operated at our centers during 2005-2013. RESULTS: Localization of BOSDs was frontal in 19, insula in 5, parietal in 5, and temporal in 3, on the convexity or interhemispheric surfaces. BOSDs were missed on initial MRI at our centers in 22% of patients. Patients presented with focal seizures during infancy in 9, preschool years in 15, and school years in 8 (median age 5 years). Seizures were stereotyped, predominantly nocturnal, and typically nonconvulsive, with semiology referable to the fronto-central or perisylvian regions. Seizures occurred at high frequency during active periods, but often went into prolonged remission with carbamazepine or phenytoin. Intellect was normal or borderline, except in patients with seizure onset during infancy. Scalp EEG frequently revealed localized interictal epileptiform discharges and ictal rhythms. Patients underwent lesionectomy (median age 14 years) guided by electrocorticography and MRI, with prior intracranial EEG monitoring in only one patient. Twenty-eight patients (88%) became seizure-free, and 20 discontinued antiepileptic medication (median follow-up 4.1 years). CONCLUSIONS: In patients with cryptogenic focal epilepsy, this clinical presentation and course should prompt review of or repeat MRI, looking for a BOSD in the frontal, parietal, or insula cortex. If a BOSD is identified, the patient might be considered for single-stage lesionectomy.
OBJECTIVE: To determine clinical and EEG features that might help identify patients with epilepsy harboring small, intrinsically epileptogenic, surgically treatable, bottom-of-sulcus dysplasias (BOSDs). METHODS: Retrospective review of clinical records, EEG, MRI, and histopathology in 32 patients with drug-resistant epilepsy and MRI-positive (72% 3.0 tesla), pathologically proven (type 2B cortical dysplasia) BOSDs operated at our centers during 2005-2013. RESULTS: Localization of BOSDs was frontal in 19, insula in 5, parietal in 5, and temporal in 3, on the convexity or interhemispheric surfaces. BOSDs were missed on initial MRI at our centers in 22% of patients. Patients presented with focal seizures during infancy in 9, preschool years in 15, and school years in 8 (median age 5 years). Seizures were stereotyped, predominantly nocturnal, and typically nonconvulsive, with semiology referable to the fronto-central or perisylvian regions. Seizures occurred at high frequency during active periods, but often went into prolonged remission with carbamazepine or phenytoin. Intellect was normal or borderline, except in patients with seizure onset during infancy. Scalp EEG frequently revealed localized interictal epileptiform discharges and ictal rhythms. Patients underwent lesionectomy (median age 14 years) guided by electrocorticography and MRI, with prior intracranial EEG monitoring in only one patient. Twenty-eight patients (88%) became seizure-free, and 20 discontinued antiepileptic medication (median follow-up 4.1 years). CONCLUSIONS: In patients with cryptogenic focal epilepsy, this clinical presentation and course should prompt review of or repeat MRI, looking for a BOSD in the frontal, parietal, or insula cortex. If a BOSD is identified, the patient might be considered for single-stage lesionectomy.
Authors: F Chassoux; S Rodrigo; F Semah; F Beuvon; E Landre; B Devaux; B Turak; C Mellerio; J-F Meder; F-X Roux; C Daumas-Duport; P Merlet; O Dulac; C Chiron Journal: Neurology Date: 2010-12-14 Impact factor: 9.910
Authors: Jason T Lerner; Noriko Salamon; Jason S Hauptman; Tonicarlo R Velasco; Marta Hemb; Joyce Y Wu; Raman Sankar; W Donald Shields; Jerome Engel; Itzhak Fried; Carlos Cepeda; Veronique M Andre; Michael S Levine; Hajime Miyata; William H Yong; Harry V Vinters; Gary W Mathern Journal: Epilepsia Date: 2009-01-21 Impact factor: 5.864
Authors: Pavel Krsek; Bruno Maton; Brandon Korman; Esperanza Pacheco-Jacome; Prasanna Jayakar; Catalina Dunoyer; Gustavo Rey; Glenn Morrison; John Ragheb; Harry V Vinters; Trevor Resnick; Michael Duchowny Journal: Ann Neurol Date: 2008-06 Impact factor: 10.422
Authors: P Krsek; B Maton; P Jayakar; P Dean; B Korman; G Rey; C Dunoyer; E Pacheco-Jacome; G Morrison; J Ragheb; H V Vinters; T Resnick; M Duchowny Journal: Neurology Date: 2008-11-12 Impact factor: 9.910
Authors: N Salamon; J Kung; S J Shaw; J Koo; S Koh; J Y Wu; J T Lerner; R Sankar; W D Shields; J Engel; I Fried; H Miyata; W H Yong; H V Vinters; G W Mathern Journal: Neurology Date: 2008-11-11 Impact factor: 9.910
Authors: Sami Barrit; Eun-Hyoung Park; Alexander Rotenberg; Harper Kaye; Phillip L Pearl; Joseph R Madsen Journal: Childs Nerv Syst Date: 2022-04-21 Impact factor: 1.532